Table 2.
Comorbidity of Metabolic Syndrome in Psoriasis.
| References | Subjects | Brief description |
|---|---|---|
| Ref.42 | German cross-sectional study (n=4,185) | Adjusted odds ratio |
| German Health Insurance beneficiaries (n=1,811,098) | Diabetes mellitus; 2.36 (95% CI 1.26-4.41) | |
| Ref.45 | Control patients (n=14,330) | Adjusted hazard ratio |
| Psoriasis (n=3,603) | Mortality from diabetes mellitus; 2.86 (95% CI 1.08-7.59) | |
| Ref.46 | Prospective study for 5.2 years follow-up | Adjusted hazard ratio |
| Control patients (n=208,187) | Diabetes mellitus; 1.18 (95% CI 1.06-1.31) | |
| Psoriasis (n=48,523) | ||
| Ref.47 | Hospital and clinic patients (n=113,065) | Adjusted odds ratio |
| Diabetes mellitus; 2.86 (95% CI 2.67-3.06) | ||
| Dyslipidemia; 2.35 (95% CI 2.19-2.52) | ||
| Ref.51 | Control patients (n=14,065) | Adjusted odds ratio in severe psoriasis |
| Severe psoriasis (n=3,854) | Diabetes mellitus; 1.62 (95% CI 1.3-2.01) | |
| Obesity; 1.79 (95% CI 1.55-2.05) | ||
| Ref.52 | Control patients (n=6,643) | Adjusted odds ratio |
| Psoriasis (n=340) | Diabetes mellitus; 1.5 (95% CI 1.2-2.0) | |
| Dyslipidemia; 1.2 (95% CI 1.0-1.6) | ||
| Obesity; 1.3 (95% CI 1.0-1.7) | ||
| Ref.53 | Control patients (n=74,987) | Adjusted odds ratio |
| Psoriasis (n=16,851) | Diabetes mellitus; 1.58 (95% CI 1.49-1.68) | |
| Ref.56 | Danish population based twin study (n=34,781 twins) | Odds ratio |
| Diabetes mellitus; 1.53 (95% CI 1.03-2.27) | ||
| Obesity; 1.81 (95% CI 1.28-2.55) | ||
| Ref.57 | Control patients (n=16,028) | Odds ratio |
| Psoriasis (n=429) | Obesity; 2.25 (95% CI 1.57-3.22) | |
| Ref.60 | Control patients (n=22,996) | Adjusted odds ratio |
| Psoriasis (n=10,669) | Dyslipidemia; 1.19 (95% CI 1.12-1.26) |